Eli Lilly Weight-Loss Pill Trial Disappoints, Offsetting Solid Profit and Sales

Key Takeaways Results from a late-stage trial of Eli Lilly's experimental weight loss pill were disappointing, sending shares of the drugmaker tumbling. The study found average weight loss from the treatment was below that of rival Novo Nordisk's Weg... [2129 chars]